Paper 47 - TARGETING DEDIFFERENTIATED LIPOSARCOMA CELL OF ORIGIN WITH TGF-BETA INHIBITION

Author(s)

• 

  Sarah Watson, MD, PhD

  Dr
  Curie
  Paris, Ile-de-France, France

  Slides

Co-Author(s)

• NG

  Nadège Gruel, PhD

  Institut Curie
  Paris, Ile-de-France, France
• BM

  Bastien Manciot, MSc

  Institut Curie
  Paris, Ile-de-France, France
• LL

  Laetitia Lesage, n/a

  Institut Curie
  Paris, Ile-de-France, France
• CQ

  Chloé Quignot, PhD

  Institut Curie
  Paris, Ile-de-France, France
• DT

  Dimitrios Tzanis, MD, PhD

  Institut Curie
  Paris, Ile-de-France, France
• SB

  Sylvie Bonvalot, MD

  Institut Curie
  Paris, Ile-de-France, France
• SE

  Sophie El Zein, MD

  Institut Curie
  Paris, Ile-de-France, France
• DD

  Didier Decaudin, MD,PhD

  Institut Curie
  Paris, Ile-de-France, France
• LL

  Laetitia Linares, PhD

  CRCM
  Montpellier, Languedoc-Roussillon, France
• OD

  Olivier Delattre, MD, PhD

  Institut Curie
  Paris, Ile-de-France, France
• JW

  Joshua Waterfall, PhD

  Institut Curie
  Paris, Ile-de-France, France
• GP

  Gaelle Pierron, PhD

  Institut Curie
  Paris, Ile-de-France, France